Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity (Mansoori, et al, 2025) #ketamine #addiction #recovery #opioids #depression #anxiety #ketaminetherapy #buprenorphine #psychedelic #psychedelics #psychedelicresearch #mentalhealth https://pubmed.ncbi.nlm.nih.gov/40247293/